Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cell therapy
cell therapy
GSK's cell therapy retreat hits another partner as drugmaker exits Immatics collaboration
Endpoints
Thu, 11/17/22 - 10:38 am
GSK
cell therapy
Immatics
Neurotech's vision loss cell therapy implant hits primary goals in phase 3 trials
Fierce Pharma
Wed, 11/9/22 - 10:36 am
neurotech
cell therapy
FDA
clinical trials
NT-501
central vision loss
Gilead dodges Supreme Court review—and a $1.2B fine—in CAR-T patent feud with Bristol Myers
Fierce Pharma
Mon, 11/7/22 - 05:48 pm
Gilead Sciences
Kite Pharma
Bristol Myers Squibb
cell therapy
legal
CAR-T
Yescarta
FDA finalizes umbrella trial guidance for cell and gene therapies
RAPS.org
Sun, 11/6/22 - 01:28 pm
FDA
regulatory
clinical trials
umbrella trials
gene therapy
cell therapy
Rubius’s New Cell Therapy Strategy Runs Out of Time & Money; Workforce Is Cut by 82%
MedCity News
Wed, 11/2/22 - 11:07 pm
Rubius Therapeutics
cell therapy
layoffs
Bone Fixes Fracture with "Synergistic" Reverse Merger, Becomes BioSenic
BioSpace
Fri, 10/28/22 - 10:36 am
Bone Therapeutics
cell therapy
M&A
reverse merger
Medsenic
BioSenic
An unusual alliance opens a gene and cell therapy hub outside Boston
BioPharma Dive
Thu, 10/27/22 - 08:29 pm
Boston
cell therapy
gene therapy
Landmark Bio
GSK axes Lyell cell therapy, passes programs to Adaptimmune
Fierce Biotech
Tue, 10/25/22 - 11:04 am
GSK
Lyell
cell therapy
Adaptimmune Therapeutics
Inceptor, Avectas are latest biotechs to take up solid tumor CAR-T challenge
Fierce Biotech
Wed, 10/12/22 - 11:44 pm
Inceptor Bio
Avectas
solid tumors
CAR-T
cell therapy
BMS-backed Immatics' cell therapy shows early promise in small data set, prompting $110M offering
Fierce Biotech
Tue, 10/11/22 - 10:04 am
Bristol Myers Squibb
Immatics
cell therapy
clinical trials
solid tumors
A Flagship cell therapy startup secures $121M in new funding
BioPharma Dive
Tue, 10/4/22 - 10:43 am
cell therapy
funding
Flagship Pioneering
Cellarity
CSL takes the wraps off a big new R&D center as it eyes vaccines, cell and gene therapies
Endpoints
Wed, 09/14/22 - 09:32 am
CSL
R&D
Germany
vaccines
gene therapy
cell therapy
Rubius makes hard pivot after reviewing clinical data, dumping lead assets and laying off 75% of staffers
Fierce Biotech
Tue, 09/13/22 - 10:44 am
Rubius Therapeutics
cell therapy
layoffs
BMS-backed Arsenal Bio pulls trigger on $220M series B, touting potential fleet of gene-edited cell therapies
Fierce Biotech
Tue, 09/6/22 - 10:39 am
Arsenal Bio
Bristol Myers Squibb
funding
cell therapy
Bayer’s BlueRock inks cardiovascular cell therapy delivery deal
Fierce Pharma
Wed, 08/31/22 - 10:22 am
Bayer
BlueRock Therapeutics
heart failure
cell therapy
BioCardia
ElevateBio finds a new manufacturing home and long-term gene therapy partner in Pittsburgh
BioPharma Dive
Thu, 08/25/22 - 07:55 pm
Elevate Bio
gene therapy
cell therapy
drug manufacturing
University of Pittsburgh
GentiBio partners with Bristol Myers as cell therapy for immune disease gain momentum
BioPharma Dive
Wed, 08/10/22 - 10:46 am
GentiBio
Bristol Myers Squibb
cell therapy
inflammatory bowel disease
ElevateBio, Boston Children’s launch startup to test new approach to ‘off-the-shelf’ cell therapy
BioPharma Dive
Fri, 08/5/22 - 10:36 am
ElevateBio
cell therapy
pediatric
Boston Children's Hospital
CAR-T
cancer
Bristol Myers CAR-T sales rise despite production problems
BioPharma Dive
Wed, 07/27/22 - 06:44 pm
Bristol Myers Squibb
cell therapy
earnings
CAR-T
Legend scraps early-stage CAR-T for lymphoma 6 weeks after clinical hold lifted
Fierce Biotech
Fri, 07/8/22 - 10:32 am
Legend Biotech
CAR-T
cell therapy
clinical trials
lymphoma
LB1901
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »